Holen Sie sich die Stockscreener-App
4.26
6.77%
0.27
Handel nachbörslich:
4.34
0.08
+1.88%
Schlusskurs vom Vortag:
$3.99
Offen:
$4.06
24-Stunden-Volumen:
489.88K
Relative Volume:
0.45
Marktkapitalisierung:
$208.10M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-67.68M
KGV:
-2.4624
EPS:
-1.73
Netto-Cashflow:
$-54.24M
1W Leistung:
-9.36%
1M Leistung:
-26.04%
6M Leistung:
-75.16%
1J Leistung:
-71.02%
1-Tages-Spanne:
$4.06
$4.31
1-Wochen-Bereich:
$3.81
$4.86
52-Wochen-Spanne:
$3.4713
$26.35
Cabaletta Bio Inc Stock (CABA) Company Profile
Firmenname
Cabaletta Bio Inc
Sektor
Branche
Telefon
(267) 759-3100
Adresse
2929 ARCH STREET, PHILADELPHIA, PA
Cabaletta Bio Inc Stock (CABA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-09-05 | Eingeleitet | Citigroup | Buy |
| 2023-07-18 | Eingeleitet | Guggenheim | Buy |
| 2023-01-27 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-08-30 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-12-08 | Eingeleitet | Wells Fargo | Overweight |
| 2021-10-19 | Fortgesetzt | Morgan Stanley | Overweight |
| 2021-06-30 | Eingeleitet | Mizuho | Buy |
| 2021-01-08 | Eingeleitet | Chardan Capital Markets | Buy |
| 2020-10-13 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-11-19 | Eingeleitet | Cowen | Outperform |
| 2019-11-19 | Eingeleitet | Evercore ISI | Outperform |
| 2019-11-19 | Eingeleitet | Morgan Stanley | Overweight |
Alle ansehen
Cabaletta Bio Inc Aktie (CABA) Neueste Nachrichten
Lynx1 Capital Management LP Lowers Stock Position in Cabaletta Bio, Inc. (NASDAQ:CABA) - MarketBeat
Cabaletta Bio to Present Key Findings on CABA-201 at ACR Convergence 2024 - MSN
Cabaletta Bio to Present Key Findings on CABA-201 at ACR Convergence 2024 - MyChesCo
Cabaletta Bio to Present New and Updated Clinical Data on CABA-201 in Oral and Poster Presentations at ACR Convergence 2024 - ForexTV.com
Fred Alger Management LLC Sells 587,432 Shares of Cabaletta Bio, Inc. (NASDAQ:CABA) - MarketBeat
Cabaletta Bio to Present New and Updated Clinical Data on CABA-201 in Oral and Poster Presentations at ACR - EIN News
Cabaletta Bio Inc (CABA) Performance and Fundamentals Dashboard tells a completely different story - SETE News
Cabaletta Bio Inc Inc. (CABA) Price Performance: The Role of Share Buybacks and Stock Splits - The InvestChronicle
Balance Sheet Breakdown: Cabaletta Bio Inc (CABA)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
Technical analysis of Cabaletta Bio Inc (CABA) stock chart patterns - US Post News
Nothing is Better Than Cabaletta Bio Inc (CABA) stock at the moment - SETE News
Cabaletta Bio Inc: Navigating Market Fluctuations with a 204.68M Market Cap - The InvestChronicle
Cabaletta Bio, Inc. (NASDAQ:CABA) Shares Purchased by E Fund Management Co. Ltd. - MarketBeat
Cabaletta Bio shares maintain Buy rating from H.C. Wainwright - Investing.com India
Cabaletta Bio (NASDAQ:CABA) Stock Rating Reaffirmed by HC Wainwright - MarketBeat
Cabaletta Bio shares maintain Buy rating from H.C. Wainwright By Investing.com - Investing.com UK
Financial Fitness Check: Examining Cabaletta Bio Inc (CABA)’s Key Ratios - The Dwinnex
Was anything positive for Cabaletta Bio Inc (CABA) stock last session? - US Post News
Cabaletta Bio, Inc. (NASDAQ:CABA) Given Average Recommendation of "Buy" by Brokerages - MarketBeat
TD Asset Management Inc Raises Holdings in Cabaletta Bio, Inc. (NASDAQ:CABA) - Defense World
Cabaletta Bio, Inc. (NASDAQ:CABA) Given Average Rating of “Buy” by Analysts - Defense World
Cabaletta Bio Inc (CABA) Stock: Navigating Drops and Gains - The InvestChronicle
Is it possible to buy Cabaletta Bio Inc(CABA) shares at a good price now? - US Post News
Metric Analysis: Cabaletta Bio Inc (CABA)’s Key Ratios in the Limelight - The Dwinnex
Several Headwinds Dragged Cabaletta Bio (CABA) in Q2 - MSN
Reviewing LadRx (OTCMKTS:CYTR) & Cabaletta Bio (NASDAQ:CABA) - Defense World
CABA Stock: A Comprehensive Analysis and Forecast - The InvestChronicle
We're Hopeful That Cabaletta Bio (NASDAQ:CABA) Will Use Its Cash Wisely - Simply Wall St
Ratios Uncovered: Breaking Down Cabaletta Bio Inc (CABA)’s Trailing Twelve Months Metrics - The Dwinnex
Is Cabaletta Bio Inc (CABA) worth investing in despite its undervalued state? - US Post News
Cabaletta Bio, Inc. (NASDAQ:CABA) Sees Significant Drop in Short Interest - MarketBeat
299,801 Shares in Cabaletta Bio, Inc. (NASDAQ:CABA) Bought by Panagora Asset Management Inc. - MarketBeat
Passage Bio CEO to Present at H.C. Wainwright Global Investment Conference - MyChesCo
Cabaletta Bio, Inc. Set to Engage at Key Investor Conferences - MSN
Financial Health Report: Cabaletta Bio Inc (CABA)’s Ratios Tell a Tale - The Dwinnex
Cabaletta Bio, Inc. Set to Engage at Key Investor Conferences - MyChesCo
Cabaletta Bio to Participate in Upcoming Investor Conferences in September - ForexTV.com
Cabaletta Bio to Participate in Upcoming Investor Conferences in September - GlobeNewswire Inc.
There is no doubt that Cabaletta Bio Inc (CABA) ticks all the boxes. - SETE News
Cabaletta Bio Inc (CABA) stock analysis: A simple moving average approach - US Post News
CABA’s Market Quandary: Decoding the Ups and Downs of 2023 - The InvestChronicle
Cabaletta Bio Welcomes Sarah Yuan, PhD, as New Chief Technology Officer - BioBuzz
Financial Analysis: Cabaletta Bio Inc (CABA)’s Ratios Unveil Key Insights - The Dwinnex
Holdings of Cabaletta Bio Inc (CABA) are aligned with the stars - SETE News
Cabaletta Bio, Inc. (NASDAQ:CABA) Given Average Rating of “Buy” by Brokerages - Defense World
Several Headwinds Dragged Cabaletta Bio (CABA) in Q2 - Insider Monkey
Several Headwinds Dragged Cabaletta Bio (CABA) in Q2 - Yahoo Finance
Cabaletta Bio, Inc. (NASDAQ:CABA) Receives $30.11 Consensus Price Target from Analysts - MarketBeat
Investing in Cabaletta Bio Inc (CABA) might be a great opportunity, but the stock is a bit overvalued - US Post News
Cabaletta Bio, Inc. (NASDAQ:CABA) Sees Significant Increase in Short Interest - MarketBeat
Stifel sees Cabaletta Bio stock poised for recovery despite recent volatility - Investing.com
Finanzdaten der Cabaletta Bio Inc-Aktie (CABA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Cabaletta Bio Inc-Aktie (CABA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Binder Gwendolyn | See Remarks |
Jan 19 '24 |
Sale |
19.59 |
11,000 |
215,439 |
20,000 |
| Binder Gwendolyn | See Remarks |
Dec 19 '23 |
Option Exercise |
1.01 |
11,000 |
11,110 |
31,000 |
| Binder Gwendolyn | See Remarks |
Dec 19 '23 |
Sale |
21.89 |
11,000 |
240,789 |
20,000 |
| Binder Gwendolyn | See Remarks |
Nov 20 '23 |
Option Exercise |
1.01 |
11,000 |
11,110 |
31,000 |
| Binder Gwendolyn | See Remarks |
Nov 20 '23 |
Sale |
17.82 |
11,000 |
196,014 |
20,000 |
| Binder Gwendolyn | See Remarks |
Oct 19 '23 |
Option Exercise |
1.01 |
11,000 |
11,110 |
31,000 |
| Binder Gwendolyn | See Remarks |
Oct 19 '23 |
Sale |
13.36 |
11,000 |
146,921 |
20,000 |
0.87%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):